These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6685902)

  • 1. Regional perfusion with cis-platinum and dacarbazine.
    Aigner K; Hild P; Henneking K; Paul E; Hundeiker M
    Recent Results Cancer Res; 1983; 86():239-45. PubMed ID: 6685902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New modifications in isolated extremity perfusion ].
    Aigner K; Hild P; Hundeiker M
    Z Hautkr; 1982 Jul; 57(14):1044-54. PubMed ID: 6889794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isolated hyperthermic extremity perfusion with vindesine, dacarbazine and cisplatin in the treatment of malignant melanomas].
    Aigner KR; Jungbluth A; Link KH; Walther H; Müller H; Schwemmle K; Ringenberg T; Börger G; Ruppel R; Illig L
    Onkologie; 1984 Dec; 7(6):348-53. PubMed ID: 6396562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated limb perfusion for stage I melanoma of the extremity: a comparison of melphalan and dacarbazine (DTIC).
    Edwards MJ; Boddie AW; Ames FC; McBride CM
    South Med J; 1989 Aug; 82(8):985-7, 989. PubMed ID: 2762904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperthermic antiblastic perfusion with DTIC in stage IIIA-IIIAB melanoma of the extremities.
    Vaglini M; Belli F; Marolda R; Prada A; Santinami M; Cascinelli N
    Eur J Surg Oncol; 1987 Apr; 13(2):127-9. PubMed ID: 3556593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional isolated perfusion of extremities for melanoma: a 20-year experience with drugs other than L-phenylalanine mustard.
    Ariyan S; Poo WJ; Bolognia J
    Plast Reconstr Surg; 1997 Apr; 99(4):1023-9. PubMed ID: 9091898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I-II trial of hyperthermic isolated limb perfusion with cisplatin in the treatment of high risk malignant melanoma of the extremities.
    Hajarizadeh H; Mueller CR; Woltering EA; Small K; Fletcher WS
    Melanoma Res; 1991; 1(1):55-61. PubMed ID: 1822770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity and complications of vascular isolation and hyperthermic perfusion with imidazole carboxamide (DTIC) in melanoma.
    Didolkar MS; Fitzpatrick JL; Jackson AJ; Johnston GS
    Cancer; 1986 May; 57(10):1961-6. PubMed ID: 3955502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated limb infusion with fotemustine after dacarbazine chemosensitisation for inoperable loco-regional melanoma recurrence.
    Bonenkamp JJ; Thompson JF; de Wilt JH; Doubrovsky A; de Faria Lima R; Kam PC
    Eur J Surg Oncol; 2004 Dec; 30(10):1107-12. PubMed ID: 15522559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional isolated perfusion of high risk melanoma of the extremities with imidazole carboxamide.
    Ariyan S; Mitchell MS; Kirkwood JM
    Surg Gynecol Obstet; 1984 Mar; 158(3):238-42. PubMed ID: 6701736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated extremity perfusion with DTIC. An experimental and clinical study.
    Aigner K; Hild P; Breithaupt H; Hundeiker M; Schwemmle K; Henneking K; Illig L; Merker G; Paul E; Brodkorb J; Jungbluth A
    Anticancer Res; 1983; 3(2):87-93. PubMed ID: 6682645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated limb perfusion with fotemustine after chemosensitization with dacarbazine in melanoma.
    Pontes L; Lopes M; Ribeiro M; Santos JG; Azevedo MC
    Melanoma Res; 1997 Oct; 7(5):417-9. PubMed ID: 9429225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated limb perfusion for melanoma.
    Kroon BB; Noorda EM; Vrouenraets BC; van Slooten GW; Nieweg OE
    Surg Oncol Clin N Am; 2008 Oct; 17(4):785-94, viii-ix. PubMed ID: 18722918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Technic of isolated perfusion of the extremities. Experience with 171 cases].
    Aigner K; Schwemmle K
    Langenbecks Arch Chir; 1983; 359(2):113-22. PubMed ID: 6681855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthermic perfusion of recurrent malignant melanoma on the extremities.
    Hafström L; Jönsson PE
    Acta Chir Scand; 1980; 146(5):313-8. PubMed ID: 7468061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of the extremities.
    Schraffordt Koops H; Kroon BB; Oldhoff J; Hoekstra HJ
    World J Surg; 1992; 16(2):241-5. PubMed ID: 1561805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolated limb hyperthermic perfusion chemotherapy for melanoma of the extremities].
    Li J; Wang P; Zhu XJ; Song JG; Song JM
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):937-9. PubMed ID: 23336382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated regional perfusion in the treatment of malignant melanomas of the extremities.
    Schraffordt Koops H; Oldhoff J; van der Ploeg E; Vermey A; Eibergen R
    Arch Chir Neerl; 1975; 27(4):237-43. PubMed ID: 1211947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Technique and results of hyperthermic perfusion of the extremity in melanoma patients].
    Omlor G; Bahmer F; Meessen S; Zang D; Feifel G; Zaun H
    Langenbecks Arch Chir; 1993; 378(1):21-5. PubMed ID: 8437498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized phase III trial of vinblastine, bleomycin, and cis-dichlorodiammine-platinum versus dacarbazine in malignant melanoma.
    Luikart SD; Kennealey GT; Kirkwood JM
    J Clin Oncol; 1984 Mar; 2(3):164-8. PubMed ID: 6199481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.